Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

alginate/fetma

Länken sparas på Urklipp
9 resultat

Composition comprising at least one alginate for use in treatment and/or prevention of overweight

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND The present invention relates to a reconstitutable composition comprising at least one alginate, an aqueous diet preparation comprising said composition and the use of the aqueous diet preparation for the treatment and/or prevention of overweight for both therapeutic and non-therapeutic

Food composition and weight loss method for treating obesity

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF INVENTION The invention relates to a method for treating overweight individuals or patients with obesity using a food composition able to control the release of glucose into the patient's blood. This is achieved by the introduction into the food composition of a hydrophilic food grade

Agent for preventing or ameliorating obesity

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION The present invention relates to an agent for preventing or ameliorating obesity, to an agent for inhibiting accumulation of visceral fat, to an agent for inhibiting accumulation of liver lipid, and to an agent for preventing or ameliorating fatty liver. BACKGROUND OF THE

Soft drink replacer

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION The present invention relates to a method for the treatment and/or prevention of overweight, said method comprising administering to a monogastric mammal a pectin and/or alginate containing liquid composition. STATE OF THE ART In effect, overweight in mammals is caused by the

Matrix-forming composition containing pectin

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION The present invention relates to a composition, which is liquid at around neutral pH and forms a viscous matrix at low pH, the composition comprising pectin, calcium and oligosaccharides. The present composition is particularly suitable for use in a method of treating or

Matrix-forming composition containing pectin

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION The present invention relates to a composition, which is liquid at around neutral pH and forms a viscous matrix at low pH, the composition comprising pectin, calcium and oligosaccharides. The present composition is particularly suitable for use in a method of treating or

Low molecular weight polymannuronate

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to low molecular weight polymannuronate, and more particularly, the present invention relates to an isolated low molecular weight polymannuronate composition, and a process for preparing thereof from high molecular

Non-reducing end unsaturated mannuronic acid oligosaccharides and compositions containing same as active ingredient

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD The present disclosure relates to non-reducing end unsaturated mannuronic acid oligosaccharides and compositions containing the same as an active ingredient. BACKGROUND In the modern world, the functional food market is expanding with the increase in complex metabolic syndromes caused by

Non-reducing end unsaturated mannuronic acid oligosaccharides and compositions containing same as active ingredient

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit and priority of Korean Patent Application No. 10-2015-0043404, filed 27 Mar. 2015. The entire disclosure of the above applications is incorporated herein by references. FIELD The present disclosure relates to non-reducing
Gå med på vår
facebook-sida

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

  • Fungerar på 55 språk
  • Växtbaserade botemedel som stöds av vetenskap
  • Örter igenkänning av bild
  • Interaktiv GPS-karta - märka örter på plats (kommer snart)
  • Läs vetenskapliga publikationer relaterade till din sökning
  • Sök efter medicinska örter efter deras effekter
  • Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning

Google Play badgeApp Store badge